Loading
ReadUpdated Oct 2, 2026
Analysis
Trade-policy analysis for import-scope decisions, written from the public record. Start from a product line, origin, supplier, or case, then read what the record changes for that file.
Published pieces336 in the archive
Current leadPolicy monitoring
SourcingCitable public records
Written forImport and customs teams
Browse
Topics
Trade policy105 piecesPolicy monitoringTrade remedies15 piecesAD/CVD ordersInjury determination+1Export controls19 piecesLicensing regimeFDPR enforcement+2Tariff authority72 piecesSection 301 trackSection 122 surcharge+2Customs enforcement33 piecesClassification and valuationUFLPA enforcement+2Metals scope review10 piecesSection 232 metalsSection 232 copper+1Origin review30 piecesUSMCA reviewAuto rules of origin+1Trade governance10 piecesAdvisory committeeEXIM reauthorization+1Entry posture review39 piecesRefund postureCAPE processing+3Tariff relief2 piecesExclusion process
Filtered
Tariff authority stream
Section 301 Has the Tariff Power. The German Drug-Pricing Case Has the Causation Problem.
Section 301 supplies the tariff power IEEPA lacked. The German drug-pricing case is weak instead on statutory fit and the causal chain to U.S. commerce.
MFN Hasn't Died. It Stopped Working as a Tariff-Planning Baseline.
Staiger's WTO reform case preserves MFN and consensus, but U.S. tariff practice after IEEPA now runs through Section 122, 232, and 301 tools that do not.
